Matthew Siskin, Jayati Saha, Emmanuel S. Antonarakis, Alessandro Leal, Samuel Parry, Jill Tsai, David R. Wise. "Real world outcomes for patients with metastatic castration resistant prostate cancer (mCRPC) and
            <i>AR</i>
            T878A alterations treated with enzalutamide.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5053